Who has invested in Ro?

General Catalyst, FirstMark Capital, TQ Ventures, Alexis Ohanian are named among the investors backing Ro.

Ro Funding: $1B Raised, Series D (2021)

Ro funding overview

Ro is a Healthtech company based in New York, NY. Ro has raised $1B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Series D announced in March 2021. The round record for Ro runs through 2021; nothing later has been disclosed. Investors on record include General Catalyst, FirstMark Capital, TQ Ventures, Alexis Ohanian. 4 distinct backers are named across the disclosed rounds.

Ro at a glance

Total raised: $1B
Latest round: Series D
Latest round date: March 2021
Industry: Healthtech
Headquarters: New York, NY
Notable investors: General Catalyst, FirstMark Capital, TQ Ventures, Alexis Ohanian

Frequently asked about Ro funding

How much has Ro raised?: Ro has raised $1B in total disclosed funding across the rounds on record.
Who has invested in Ro?: General Catalyst, FirstMark Capital, TQ Ventures, Alexis Ohanian are named among the investors backing Ro.
What was the latest Ro funding round?: The most recent disclosed round is a Series D, announced in March 2021.
Where is Ro based?: Ro is based in New York, NY.
What sector does Ro operate in?: Ro is tracked under Healthtech from New York, NY, with $1B in disclosed funding.
When did Ro last raise?: The last disclosed Ro round closed in March 2021 at Series D.

We update the Ro record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies in New York and their backers are listed below.

Ro Funding: $1B Raised, Series D (2021)

Ro funding overview

Ro at a glance

Frequently asked about Ro funding

Companies related to Ro (40)

Browse related funding lists (9)